| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Foote Susan Bartlett is a Director at HAE. Recent filings cover 0 purchases and 37 sales. Those positions are worth an estimated $1.9M at current prices.
Foote Susan Bartlett's largest disclosed position is in HAE as Director, worth about $1.9M. The recent filings there lean toward selling, a net 58,253 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2017 | HAE Haemonetics Corp | Director | Sale+OE | 16,926 | $54.19 | $917,279.21 | -2.4% | |
| May 11, 2017 | HAE Haemonetics Corp | Director | Sale+OE | 15,314 | $41.78 | $639,818.92 | -53.6% | |
| Aug 5, 2016 | HAE Haemonetics Corp | Director | Sale+OE | 14,685 | $35.35 | $519,105.45 | -9.7% | |
| Mar 10, 2015 | HAE Haemonetics Corp | Director | Sale+OE | 11,328 | $43.84 | $496,641.04 | -47.9% |